Product Images Gomekli
View Photos of Packaging, Labels & Appearance
- GOMEKLI capsules and tablets for oral suspension contain mirdametinib, a kinase inhibitor. Mirdametinib is chemically known as (R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2- fluoro-4-iodophenyl)amino) benzamide. The molecular formula is C16H14 F3IN2O4 and the molecular weight is 482.20 g/mol. The structural formula for mirdametinib is: - mirdametinib tablet 01
- STEP 2 - mirdametinib tablet 02
- step 3 - mirdametinib tablet 03
- step 4 - mirdametinib tablet 04
- step 5 - mirdametinib tablet 05
- 2-4 min - mirdametinib tablet 06
- step a1 - mirdametinib tablet 07
- step a2 - mirdametinib tablet 08
- step a3 - mirdametinib tablet 09
- step a4 - mirdametinib tablet 0a
- step a5 - mirdametinib tablet 0b
- step b1 - mirdametinib tablet 0c
- step b2 - mirdametinib tablet 0d
- step b3 - mirdametinib tablet 0e
- step b4 - mirdametinib tablet 0f
- step b5 - mirdametinib tablet 10
- step b6 - mirdametinib tablet 11
- step b7 - mirdametinib tablet 12
- PRINCIPAL DISPLAY PANELNDC 82448-134-84GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet84 Tablets - mirdametinib tablet 13
- PRINCIPAL DISPLAY PANELNDC 82448-134-84GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet84 Tablets - mirdametinib tablet 14
- PRINCIPAL DISPLAY PANELNDC 82448-134-42GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet42 Tablets - mirdametinib tablet 15
- PRINCIPAL DISPLAY PANELNDC 82448-134-42GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet42 Tablets - mirdametinib tablet 16
- PRINCIPAL DISPLAY PANELNDC 82448-130-42GOMEKLITM (mirdametinib) Capsules1 mgper Capsules42 Capsules - mirdametinib tablet 17
- PRINCIPAL DISPLAY PANELNDC 82448-130-42GOMEKLITM (mirdametinib) Capsules1 mgper Capsules42 Capsules - mirdametinib tablet 18
- PRINCIPAL DISPLAY PANELNDC 82448-260-42GOMEKLITM (mirdametinib) Capsules2 mgper Capsules42 Capsules - mirdametinib tablet 19
- PRINCIPAL DISPLAY PANELNDC 82448-260-42GOMEKLITM (mirdametinib) Capsules2 mgper Capsules42 Capsules - mirdametinib tablet 1a
- PRINCIPAL DISPLAY PANELNDC 82448-260-84GOMEKLITM (mirdametinib) Capsules2 mgper Capsules84 Capsules - mirdametinib tablet 1b
- PRINCIPAL DISPLAY PANELNDC 82448-260-84GOMEKLITM (mirdametinib) Capsules2 mgper Capsules84 Capsules - mirdametinib tablet 1c
Product Label Images
The following 28 images provide visual information about the product associated with Gomekli NDC 82448-130 by Springworks Therapeutics, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
GOMEKLI capsules and tablets for oral suspension contain mirdametinib, a kinase inhibitor. Mirdametinib is chemically known as (R)-N-(2,3-dihydroxypropoxy)-3,4-difluoro-2-((2- fluoro-4-iodophenyl)amino) benzamide. The molecular formula is C16H14 F3IN2O4 and the molecular weight is 482.20 g/mol. The structural formula for mirdametinib is: - mirdametinib tablet 01
STEP 2 - mirdametinib tablet 02
step 3 - mirdametinib tablet 03
step 4 - mirdametinib tablet 04
step 5 - mirdametinib tablet 05
2-4 min - mirdametinib tablet 06
step a1 - mirdametinib tablet 07
step a2 - mirdametinib tablet 08
step a3 - mirdametinib tablet 09
step a4 - mirdametinib tablet 0a
step a5 - mirdametinib tablet 0b
step b1 - mirdametinib tablet 0c
step b2 - mirdametinib tablet 0d
step b3 - mirdametinib tablet 0e
step b4 - mirdametinib tablet 0f
step b5 - mirdametinib tablet 10
step b6 - mirdametinib tablet 11
step b7 - mirdametinib tablet 12
PRINCIPAL DISPLAY PANELNDC 82448-134-84GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet84 Tablets - mirdametinib tablet 13
PRINCIPAL DISPLAY PANELNDC 82448-134-84GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet84 Tablets - mirdametinib tablet 14
PRINCIPAL DISPLAY PANELNDC 82448-134-42GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet42 Tablets - mirdametinib tablet 15
PRINCIPAL DISPLAY PANELNDC 82448-134-42GOMEKLITM (mirdametinib) Tablets for oral suspension1 mgper tablet42 Tablets - mirdametinib tablet 16
PRINCIPAL DISPLAY PANELNDC 82448-130-42GOMEKLITM (mirdametinib) Capsules1 mgper Capsules42 Capsules - mirdametinib tablet 17
PRINCIPAL DISPLAY PANELNDC 82448-130-42GOMEKLITM (mirdametinib) Capsules1 mgper Capsules42 Capsules - mirdametinib tablet 18
PRINCIPAL DISPLAY PANELNDC 82448-260-42GOMEKLITM (mirdametinib) Capsules2 mgper Capsules42 Capsules - mirdametinib tablet 19
PRINCIPAL DISPLAY PANELNDC 82448-260-42GOMEKLITM (mirdametinib) Capsules2 mgper Capsules42 Capsules - mirdametinib tablet 1a
PRINCIPAL DISPLAY PANELNDC 82448-260-84GOMEKLITM (mirdametinib) Capsules2 mgper Capsules84 Capsules - mirdametinib tablet 1b
PRINCIPAL DISPLAY PANELNDC 82448-260-84GOMEKLITM (mirdametinib) Capsules2 mgper Capsules84 Capsules - mirdametinib tablet 1c
